Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Levi

Showing results (91-100 of 393) with videos related to

Pageof 40
Sort By:
BMJ (Clinical Research Ed.)|January 6, 2018
Urgent reversal of vitamin K antagonistsBeverley J Hunt, Marcel Levi
Seminars in Thrombosis and Hemostasis|October 29, 2008
Thrombocytopenia in critically ill patientsMarcel Levi, Ester C Löwenberg
Seminars in Thrombosis and Hemostasis|December 17, 2013
The potential therapeutic benefit of targeting ADAMTS13 activityElise S Eerenberg, Marcel Levi
British Journal of Haematology|June 3, 2020
Re The source of elevated plasma D-dimer levels in COVID-19 infectionBeverley J Hunt, Marcel Levi
Thorax|June 30, 2007
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injuryMarcus J Schultz, Marcel Levi
Intensive Care Medicine|February 22, 2017
What do sepsis-induced coagulation test result abnormalities mean to intensivists?Marcel Levi, Marcus J Schultz
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Thrombosis and coagulopathy in COVID-19: An illustrated reviewMarcel Levi, Beverley J Hunt
JAMA Internal Medicine|February 17, 2016
What Other Industries Can Learn From Health CareW Joost Wiersinga, Marcel Levi
Intensive Care Medicine|March 8, 2006
Prescription of rh-APC differs substantially among western European countriesMarcus J Schultz, Marcel Levi
Seminars in Thrombosis and Hemostasis|January 5, 2008
Clinical relevance of the effects of plasma expanders on coagulationMarcel Levi, Evert de Jonge
Pageof 40

Showing results (91-100 of 393) with videos related to

Sort By:
Pageof 40
BMJ (Clinical Research Ed.)|January 6, 2018
Urgent reversal of vitamin K antagonistsBeverley J Hunt, Marcel Levi
Seminars in Thrombosis and Hemostasis|October 29, 2008
Thrombocytopenia in critically ill patientsMarcel Levi, Ester C Löwenberg
Seminars in Thrombosis and Hemostasis|December 17, 2013
The potential therapeutic benefit of targeting ADAMTS13 activityElise S Eerenberg, Marcel Levi
British Journal of Haematology|June 3, 2020
Re The source of elevated plasma D-dimer levels in COVID-19 infectionBeverley J Hunt, Marcel Levi
Thorax|June 30, 2007
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injuryMarcus J Schultz, Marcel Levi
Intensive Care Medicine|February 22, 2017
What do sepsis-induced coagulation test result abnormalities mean to intensivists?Marcel Levi, Marcus J Schultz
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Thrombosis and coagulopathy in COVID-19: An illustrated reviewMarcel Levi, Beverley J Hunt
JAMA Internal Medicine|February 17, 2016
What Other Industries Can Learn From Health CareW Joost Wiersinga, Marcel Levi
Intensive Care Medicine|March 8, 2006
Prescription of rh-APC differs substantially among western European countriesMarcus J Schultz, Marcel Levi
Seminars in Thrombosis and Hemostasis|January 5, 2008
Clinical relevance of the effects of plasma expanders on coagulationMarcel Levi, Evert de Jonge
Pageof 40